VanEck Pharmaceutical ETF (NASDAQ:PPH) Shareholders to Get $0.36 Quarterly Dividend

VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) announced a quarterly dividend on Wednesday, September 30th. Stockholders of record on Thursday, October 1st will be given a dividend of $0.36 per share on Tuesday, October 6th. This represents a $1.44 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Thursday, October 1st. This is a 42.4% decrease from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248.

VanEck Pharmaceutical ETF Stock Down 1.5%

PPH opened at $109.47 on Thursday. The firm has a market cap of $1.03 billion, a price-to-earnings ratio of 20.21 and a beta of 0.46. VanEck Pharmaceutical ETF has a 52 week low of $90.60 and a 52 week high of $118.00. The business’s 50 day moving average is $112.19 and its two-hundred day moving average is $107.16.

VanEck Pharmaceutical ETF Company Profile

(Get Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

Featured Articles

Dividend History for VanEck Pharmaceutical ETF (NASDAQ:PPH)

Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.